Delhi High Court allow NATCO to launch CTPR and its formulations through non-fringing process

Natco Pharma today received approval from High Court of Delhi to launch Chlorantraniliprole (CTPR) and its formulations market estimated INR 2000 Crores, through its non-infringing process. Chlorantraniliprole (CTPR) is a broad spectrum insecticides used across wide range of crops for pest management. Registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) recorded in its Minutes of the 425th Meeting held on 25 January 2021, for indigenous manufacture of Chlorantraniliprole (CTPR) Technical 93.00% w/w min. under Section 9(3).CTPR technical is formulated into broad spectrum insecticides used across wide range of crops for pest management.

Leave a Reply

Shopping Cart
Scroll to Top